直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Fintiv Refined: USPTO Provides Interim Procedure for Discretionary Denials

June 22, 2022

Authored and Edited by Trenton A. Ward; Joshua L. Goldberg

On June 22, 2022, the USPTO issued guidance on an Interim Procedure for Discretionary Denials (“Guidance”). In the Guidance, Director Vidal notes that the office is planning to explore rulemaking regarding discretionary denials, but, “in the meantime . . . several clarifications need to be made to the PTAB's current application of Fintiv to discretionary institution where there is parallel litigation.”  The memo provides that this guidance is binding on the PTAB, as it is issued under the Director’s authority to govern the PTAB’s implementation of various statutory provisions.  Guidance at 3.

In accordance with the Guidance, the “PTAB will not deny institution of an IPR or PGR under Fintiv” in the following scenarios:

  1. Unpatentability is Compelling: “when a petition presents compelling evidence of unpatentability”
  2. Parallel Case is Before the ITC: “when a request for denial under Fintiv is based on a parallel ITC proceeding”
  3. Sotera Stipulation Made: “where a petitioner stipulates not to pursue in a parallel district court proceeding the same grounds as in the petition or any grounds that could have reasonably been raised in the petition”

Id. at 9.

Compelling Challenges Will Not Be Denied Institution Under Fintiv

The Guidance provides that if a compelling unpatentability challenge is presented in an IPR or PGR petition, “that determination alone demonstrates that the PTAB should not discretionarily deny institution under Fintiv.”  Id. at 5.  In support of this procedure, the memo states that Congress provided the Office with significant power to revisit and revise earlier patent grants as a mechanism to improve patent quality.  Id. at 4.  Thus, “compelling, meritorious challenges will be allowed to proceed at the PTAB even where district court litigation is proceeding in parallel.”  Id.

Fintiv Does Not Apply to ITC Cases

The Guidance notes that the PTAB’s NHK Spring precedential case considered a parallel district court proceeding and that the Fintiv factors “focus on the interplay between IPRs and district court litigation.”  Id. at 5-6. Furthermore, the memo identifies differences between ITC investigations and district court patent litigation, including the fact that the ITC lacks the authority to invalidate a patent and its invalidity rulings are not binding on the USPTO or a district court.  Id. at 6.  Accordingly, the Guidance states that denying institution in favor of a parallel ITC investigation will not necessarily minimize conflicts with a PTAB proceeding or a district court proceeding.  Id.  Thus, “the PTAB no longer discretionarily denies petitions based on applying Fintiv to a parallel ITC proceeding.”  Id. at 7. 

Sotera Stipulations

If both the PTAB and a district court are adjudicating the same validity issues, it is possible that conflicting decisions could be rendered.  Thus, factor 4 of Fintiv looks at the overlap between the issues raised in an IPR or PGR petition and a parallel district court proceeding.  The Guidance provides, however, that a stipulation by a petitioner that it will not pursue in district court litigation the same grounds as in the petition or that could have reasonably been raised in the petition can mitigate the concern of potentially conflicting decisions.  Id. at 7.  Thus, “the PTAB will not discretionarily deny institution of an IPR or PGR in view of parallel district court litigation where a petitioner stipulates not to pursue” grounds raised or that reasonably could have been raised in the petition.  Id.

Consideration of Median Time-To-Trial Statistics

The PTAB’s reliance on a district court’s scheduled trial date for Fintiv consideration has been an issue that has drawn significant comment.  The Guidance provides that “[s]takeholders correctly noted that scheduled trial dates are unreliable and often change.” Id. at 8.  Thus, a district court’s scheduled trial date, by itself, is not a good indicator of whether the PTAB’s final written decision will be released before the district court trial.  Id.  The Guidance provides that parties may present “median time-to-trial for civil actions in the district court.” Id. at 8-9.  Accordingly, the PTAB will consider the speed with which the district court case may come to trial and be resolved.  Id. at 9.

Tags

United States Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (PTAB), International Trade Commission (ITC), Fintiv, discretionary denials

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Atlanta, GA

Washington, DC

Contacts

Joshua L. Goldberg
Partner
Reston, VA
+1 202 408 6092
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Federal Circuit IP Blog

Federal Circuit Vacates and Remands Infringement and Damages Judgment After Erroneous Verdict Form and Eligibility Analysis

July 8, 2026

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for March–May 2026

July 2, 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: May 2026

June 30, 2026

Articles

How Low Can You Go? Courts Lower Marking Defense Burden, Raising Patent Damages Risks

June 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP